ebook Munafa Stock Market Course + Intraday & FNO calls  

       

MA NEWS why is Mastercard Incorporated price falling or rising

MA NEWS reasons for why stock price of Mastercard Incorporated is falling or rising

MA Mastercard Incorporated is falling or rising technical reasons

Technical analysis forecast for Mastercard Incorporated Stock is that its in a downtrend for shortterm, and I will avoid taking a BUY or a LONG trade in this stock. Look for opportunities to sell or SHORT Mastercard Incorporated MA at this time. Stock is falling and might fall more.

It appears as if Mastercard Incorporated MA gave a large move recently.

Stock of Mastercard Incorporated (MA) is trading below an important moving average line, and it has been below this line for quite some time now. This is not a good sign, stock might keep falling and stock might move lower...

My analysis of Mastercard Incorporated is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if Mastercard Incorporated stays below 496.1, but if it comes above 496.1, then a intra day buy could be more profitable.
If you take a sell trade below 496.1, then use 496.1 as stoploss and 485.4 as target. However if you take a buy trade in Mastercard Incorporated, then use 496.1 as stoploss and 504.94 as target.

MA Mastercard Incorporated is falling or rising NEWS fundamental reasons

Why Prada has a devil of a dilemma, but so does India Prada Kolhapuri controversy: The latest collection from high-fashion label Prada has ignited a firestorm in India again. This comes a year after their initial line caused a big copying row. Now, the brand's attempt at damage control has come under severe s - NEWS as on 2026-05-07 indiatimes.com

Sun Pharma explores funding mix for billion Organon deal Global lenders are exploring various financing options for Sun Pharmaceutical Industries' proposed billion acquisition of Organon & Co. The Indian drugmaker is considering swapping Organon bondholders into Sun Pharma debt and a potential euro-denom - NEWS as on 2026-05-06 indiatimes.com

Pharma exports surpass billion in FY26 despite global headwinds Indian pharmaceutical exports reached over billion in FY26. March saw a significant 23% drop, primarily due to a slowdown in the United States and China. However, other markets like Africa and Oceania showed strong growth. Vaccines emerged as the faste - NEWS as on 2026-05-05 indiatimes.com

Two separate venues for pharma industry expos in Delhi-NCR CPHI India and PMEC India are expanding their pharmaceutical expos to two venues in Delhi-NCR. This move aims to support the rapid growth of India's pharma sector. The events will offer greater business engagement and specialized networking. CPHI India wil - NEWS as on 2026-05-03 indiatimes.com

The Most Important Part of These 3 Big Pharma Earnings Reports Wasn’t the Beat Earnings season is in full swing, and on April 29, three Big Pharma mainstays reported Q1 2026 earnings. Investors were looking for strong results—and strong guidance—that could serve as a sorely needed tailwind for the healthcare sector. So fa - NEWS as on 2026-05-02 nasdaq.com

Pre-Market Earnings Report for April 30, 2026 : LLY, MA, CAT, MRK, COP, PH, BMY, MO, SO, TT, PWR, ICE The following companies are expected to report earnings prior to market open on 04/30/2026. Visit our Earnings Calendar for a full list of expected earnings releases.Eli Lilly and Company (LLY)is reporting for the quarter ending March 31, 2026. The large - NEWS as on 2026-04-29 nasdaq.com

Sun Pharma shares rally 9% in two days after -bn Organon deal. Here's what Morgan Stanley, other brokerages say Sun Pharmaceutical Industries' shares surged nearly 9% after announcing the .75 billion acquisition of Organon & Co., a global leader in women's health. The deal diversifies Sun Pharma's portfolio into women's health and biosimilars, with analysts f - NEWS as on 2026-04-28 indiatimes.com

Sun Pharma deal structurally strong, debt the only overhang: Amit Khurana Market expert Amit Khurana offers insights on key corporate and regulatory developments. Sun Pharma's acquisition is seen as strategically sound, though debt requires careful management. Paytm Payments Bank's license cancellation has limited impact on its - NEWS as on 2026-04-27 indiatimes.com

ET Exclusive | Sun Pharma set to acquire Organon for .5 bn, its biggest till date US company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai HQed company pips the consortium of EQT-Gruenthal. Sun will pay .5 billion for Organon’s equity and inherit .5 bil - NEWS as on 2026-04-26 indiatimes.com

Buy the dip, but avoid IT, back pharma & power, says Rudramurthy BV Indian markets are experiencing a healthy correction, according to Vachana Investments' MD, CA Rudramurthy BV. He advises waiting for specific levels around Nifty 23,700-23,800 and Bank Nifty 55,000 for buying opportunities. He highlights strength in phar - NEWS as on 2026-04-24 indiatimes.com

Microdrama apps chase telco bundles as subscription growth lags despite download surge Microdrama platforms are partnering with telecom operators to combat market fragmentation and boost subscriptions. With over 20 apps and significant growth, the sector faces challenges in monetizing through advertising. Telcos aim to replicate successful O - NEWS as on 2026-04-23 indiatimes.com

Govt's ammonia rule to hurt pharma cos as directive restricts sale of surplus to fertiliser firms India’s pharmaceutical industry faces a potential raw material crunch after the government restricted surplus ammonia supply to fertiliser use. Drugmakers warn the move could disrupt API production, cause medicine shortages and impact exports, as ammonia i - NEWS as on 2026-04-22 indiatimes.com

More announcements and NEWS

MA Mastercard Incorporated current price & indicator signals

Moving Averages for Mastercard Incorporated

  • 5Day Average: 498.41
  • 12Day Average: 504.95
  • 20Day Average: 508
  • 50Day Average: 506.43
  • 100Day Average: 528.21
  • 150Day Average: 537.31
  • 200Day Average: 547.57

MA Indicators & signals

Indicator MACD (12,26,9)

503.39, 505.73, -0.58
Indicator MACD is in negative zone

Indicator ADX (14)

17.23, 19.08, 27.02
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 46
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of MA Mastercard Incorporated are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
06 Wed May 2026 491.83 489.73 to 500.74 -1.06% 0.7 times
05 Tue May 2026 497.08 493.26 to 503.88 -1.52% 1.12 times
04 Mon May 2026 504.74 493.88 to 507.29 1.87% 1.17 times
01 Fri May 2026 495.46 492.15 to 509.00 -1.48% 1.2 times
30 Thu Apr 2026 502.92 498.96 to 514.15 -4.25% 1.58 times
29 Wed Apr 2026 525.23 520.89 to 534.21 3.47% 1.55 times
28 Tue Apr 2026 507.62 507.24 to 517.00 0.23% 1.03 times
27 Mon Apr 2026 506.43 500.76 to 509.05 0.45% 0.67 times
24 Fri Apr 2026 504.17 495.63 to 505.61 0.36% 0.64 times
23 Thu Apr 2026 502.38 498.37 to 509.65 -1.53% 0.72 times
22 Wed Apr 2026 510.21 505.72 to 513.89 -0.22% 0.33 times
21 Tue Apr 2026 511.35 510.17 to 523.11 -1.06% 0.91 times

Videos related to: MA NEWS why is Mastercard Incorporated price falling or rising

Hindi Basics How To Trade In FnO Futures Options Stock Market

MA NEWS why is Mastercard Incorporated price falling or rising

 

Back to top